Key result
The anti-FXa assay was unaffected by pre-analytical variables such as intentional short-draws, unlike the aPTT assay.
Why the study?
Is the anti-FXa assay less affected by pre-analytical variables than the aPTT assay when monitoring patients on UFH or LMWH?
Observational (n=46)
Is the anti-FXa assay less affected by pre-analytical variables than the aPTT assay when monitoring patients on UFH or LMWH?
The anti-FXa assay is less affected by pre-analytical variables such as sodium citrate concentration and short-draws compared to the aPTT assay for monitoring heparin therapy.
Answers are grounded in this paper and cite their sources.
Anti-FXa may offer more reliable UFH/LMWH monitoring amid pre-analytical variability; hypothesis-generating for prospective outcome trials.
The purpose of this study was to determine whether the anti-activated factor X (anti-FXa) assay is less affected by pre-analytical variables in monitoring patients on unfractionated heparin (UFH) and low molecular weight heparin (LMWH) than the activated partial thromboplastin time (aPTT). Forty-six subjects receiving either enoxaparin (LMWH) or UFH were randomly selected. Each study subject had six vacutainer tubes (3.8% sodium citrate, 3.2% sodium citrate) drawn by an atraumatic venipuncture. One tube from each set had a blood to anticoagulant ratio of 9: 1. The other tube had an intentional "short-draw" of approximately 6: 1 blood to anticoagulant ratio. All specimens had an aPTT and a chromogenic anti-FXa assay performed on each specimen regardless of heparin type. The aPTT assay mean with the 3.8% sodium citrate tube short-draw tube was statistically different from the other aPTT assays (P = 0.06). However, all six of the mean anti-FXa assays for the UFH and LMWH heparin subjects were not statistically or clinically different (analysis of variance, P = 0.9878 for UFH and P = 0.9060 for LMWH). The intentional short-draw tube did not affect the anti-FXa assay regardless of the anticoagulant. The anti-FXa assay appears to be a better method for monitoring heparin subjects than the aPTT due to the lack of effect of pre-analytical variables.
No takes yet. Share an insight, caveat, or question.
McGlasson et al. (2005) conducted an observational in Receiving unfractionated heparin (UFH) or low molecular weight heparin (LMWH) (n=46). Intentional short-draw (6:1 ratio) and varying sodium citrate concentrations (3.8% vs 3.2%) vs. Standard blood to anticoagulant ratio (9:1) was evaluated on Mean anti-FXa and aPTT assay results across different pre-analytical variables (p=0.9878 for UFH and 0.9060 for LMWH). The anti-FXa assay was unaffected by pre-analytical variables such as intentional short-draws, unlike the aPTT assay.
Synapse has enriched 10 related papers. Consider them for comparative context: